drug

meloxicam

1 story · latest Aug 6, 2026

Status: FDA approved Jun 2004 · NDA021530, NDA217593, NDA218395
Brands: Qamzova, Xifyrm

Relationships

Developed by Skye Bioscience, Inc.

Timeline

Viatris raises 2026 guidance, reports FDA approvals and Tyrvaya sale in Q2 update

Aug 6Quarterly updatevarenicline Viatris Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.